Pharma & Biotech

Shares of genome-editing company Intellia Therapeutics closed the trading week in negative territory, continuing a period of pronounced weakness. The...

The biotechnology firm CureVac is approaching its final days as a publicly traded company on the NASDAQ. The acquisition by...

Shares of the biotechnology firm Allogene Therapeutics experienced a notable decline during the previous trading session. The move lower occurred...

While BioNTech SE achieved a major strategic objective this week, investor sentiment was dominated by emerging regulatory headwinds from the...

A dramatic power struggle is unfolding at ophthalmic device maker Staar Surgical, casting severe doubt over its pending acquisition by...

The pharmaceutical giant Teva is currently charting a remarkable recovery narrative. Having navigated years of consolidation and debt reduction, the...

Pharmaceutical titan Eli Lilly has delivered significant news on two distinct fronts, capturing investor attention. Beyond the intense spotlight on...

The disconnect between a company's operational performance and its stock market valuation is rarely as stark as the current situation...

Investors in Redcare Pharmacy are witnessing a severe disconnect. While the company's operational performance shows robust growth, its equity value...

The intersection of quantum computing and healthcare is drawing a skeptical eye from investors. IonQ, a leader in developing commercial...